Gourley, Charlie

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

Moore, K., Colombo, N., Scambia, G., Kim, B.-G., Oaknin, A., Friedlander, M., Lisyanskaya, A., Floquet, A., Leary, A., Sonke, G. S., et al. (2018) · New England Journal of Medicine

PARP inhibition in cancer therapyBRCA gene mutations in cancer

Cited by 2,870

Overall survival with maintenance Olaparib at a 7-year follow-up in patients with newly diagnosed advanced ovarian cancer and a BRCA mutation: the SOLO1/GOG 3004 trial

DiSilvestro, P., Banerjee, S., Colombo, N., Scambia, G., Kim, B.-G., Oaknin, A., Friedlander, M., Lisyanskaya, A., Floquet, A., Leary, A., et al. (2023) · Journal of Clinical Oncology

PARP inhibition in cancer therapyBRCA gene mutations in cancer

Cited by 511

Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): A multicentre randomised controlled effectiveness trial

Sharpe, M., Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Gourley, C., Wall, L., Weller, D., & Murray, G. (2014) · The Lancet

Cancer survivorship and careMental Health Treatment and Access

Cited by 269

HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer

Stronach, E. A., Alfraidi, A., Rama, N., Datler, C., Studd, J. B., Agarwal, R., Guney, T. G., Gourley, C., Hennessy, B. T., Mills, G. B., et al. (2011) · Cancer Research

Ovarian cancer diagnosis and treatmentHistone Deacetylase Inhibitors Research

Cited by 176

Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer

Walker, J., Hansen, C. H., Martin, P., Symeonides, S., Gourley, C., Wall, L., Weller, D., Murray, G., & Sharpe, M. (2014) · The Lancet Oncology

Cancer survivorship and careMental Health Treatment and Access

Cited by 155

Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions

Karam, A., Ledermann, J. A., Kim, J.-W., Sehouli, J., Lu, K., Gourley, C., Katsumata, N., Burger, R. A., Nam, B.-H., Bacon, M., et al. (2017) · Annals of Oncology

Ovarian cancer diagnosis and treatmentEndometrial and Cervical Cancer Treatments

Cited by 153

Major Depression and Survival in People With Cancer

Walker, J., Mulick, A., Magill, N., Symeonides, S., Gourley, C., Burke, K., Belot, A., Quartagno, M., van Niekerk, M., Toynbee, M., et al. (2021) · Psychosomatic Medicine

Cancer survivorship and careCancer, Stress, Anesthesia, and Immune Response

Cited by 124

Mismatch repair deficiency in ovarian cancer — Molecular characteristics and clinical implications

Xiao, X., Melton, D. W., & Gourley, C. (2014) · Gynecologic Oncology

BRCA gene mutations in cancerGenetic factors in colorectal cancer

Cited by 89

Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials

Mulick, A., Walker, J., Puntis, S., Burke, K., Symeonides, S., Gourley, C., Wanat, M., Frost, C., & Sharpe, M. (2018) · The Lancet Psychiatry

Cancer survivorship and careCardiac Health and Mental Health

Cited by 60

Depression and anxiety during the year before death from cancer

Magill, N., Walker, J., Symeonides, S., Gourley, C., Hobbs, H., Rosenstein, D., Frost, C., & Sharpe, M. (2022) · Journal of Psychosomatic Research

Cancer survivorship and carePalliative and Oncologic Care

Cited by 9

PISARRO: A EUTROC phase 1b study of APR-246 with carboplatin (C) and pegylated liposomal doxorubicin (PLD) in relapsed platinum-sensitive high grade serous ovarian cancer (HGSOC)

Basu, B., Gourley, C., Gabra, H., Vergote, I. B., Brenton, J. D., Abrahmsen, L., Smith, A., Von Euler, M., & Green, J. A. (2016) · Annals of Oncology

Ovarian cancer diagnosis and treatmentPARP inhibition in cancer therapy

Cited by 8